“showed a trend”

Although DEX had no significant impact on expression of UPR-related transcription factors, ATF4 showed a trend of reduced transcript levels after DEX treatment ( p = 0.054, Supplementary Figure 6 ).

Healing status was significantly associated with OS in univariable analysis (HR 0.52, p = 0.021) and RFS showed a trend ( p = 0.054) in the same direction.

The ratio of Aβ 40 :Aβ 38 showed a trend toward decreased Aβ 40 , which bordered on significance in CSF ( P = .054) and CM ( P = .028) ( Table 1 ). 3.3.

Patients with Severe Sarcopenia and eGFR < 60 mL/min/1.73 m 2 In patients with eGFR < 60 mL/min/1.73 m 2 , severe sarcopenia was associated with older age, and showed a trend toward lower sarcopenic index values ( p = 0.054) ( Table 8 ).

Similarly, BMI showed a trend towards higher values in Group 2 ( p = 0.054).

Although LGR5 + cell populations were expanded, there was no change in WNT target gene expression, including cyclin D1 , C-MYC , DKK1 , or β-CATENIN , and AXIN2 expression showed a trend to be decreased in SBS compared with normal biopsies ( Figure 4A, P = 0.054).

Baseline antibiotics showed a trend toward association ( p = 0.054).

Left toe-off showed a trend for greater TFL at colder temperatures ( p = 0.054, η p 2 = 0.209).

UE patients showed a trend of better overall weaning rate (71.9% vs 66.7%, P = .054) than non-UE.

On POD3 patients without EAD showed a trend towards lower Sdc-1 concentration (median POD3 no EAD: 379 ng/mL vs. median POD3 EAD: 734 ng/mL, P=0.054), whereas lower Sdc-1 concentrations were seen in patients without EAD on POD7 (median POD7 no EAD: 288 ng/mL vs. median POD7 EAD: 577 ng/mL, P=0.04) as seen in Figure 1B .

20 Final OS analysis showed a trend toward improvement in the all-comers population ( p = 0.054, 48% maturity).

In the univariable analysis, patients with high‐risk cytogenetics showed a trend toward an increased likelihood of disease progression (HR 1.34, 95% CI: 1.00–1.81; p = 0.054) and a significantly increased risk of death (HR 2.08, 95% CI: 1.33–3.26; p = 0.001).

However, patients with initial shockable rhythm showed a trend towards a higher incidence of acute coronary lesions (29.7% vs 16.4%, P = 0.054) and higher rate of ad-hoc PCI (21.9% vs 9.1%, P = 0.03), mainly for left anterior descending artery lesions (45.9%).

Additionally, low levels of HPS5 showed a trend towards being associated with longer PFS (log-rank p = 0.054) and were significantly associated with longer OS (log-rank p < 0.001).

Galanin intensity showed a trend of negative correlation with TNM staging of the tumors (P-value =0.054, Pearson correlation of -0.215).

Median TTP showed a trend of prolongation in DCF regimen without reaching statistically significant difference (p = 0.054) ( Figure 5 ).

However, the colocalization of GnRH and vGluT2 punta density only showed a trend for a decrease (P = 0.054) that, together with the different ages at which GnRH (young to old) and vGluT2 (young to MA) decreased, suggests that the age-related decline of vGluT2 in the median eminence was probably not associated specifically with the GnRH system.

When conducting ANOVA at individual time points, only the 3-month period showed a trend (p = 0.054) for the same Stress*Dye interaction.

In patients with biliary stents cultured, use of TZP ppx showed a trend towards lower rates of culture positive SSIs compared to non-TZP ppx (9.1% vs 29.4%, p=0.054).

The ANOVA on change in FAR from T2 to T3 showed a trend for a Group effect ( F 1,38 = 3.94, p = 0.054, η 2 p = 0.09; BF 10 = 1.451; Figure 5d ), with greater change for the SF, but no significant Type effect ( F 1,38 = 0.281, p = 0.599, η 2 p = 0.01; BF 10 = 0.237) and Type × Group effect ( F 1,38 = 0.311, p = 0.580, η 2 p = 0.01; BF 10 = 0.306). 3.6.

Univariate analysis for OS showed a trend for worse 1‐year OS in the CD3 LOW group (54.9%, 95% CI 29.2–74.7%) compared to the CD3 HIGH group (84.2%, 95% CI 47.0–96.2%; p = 0.054) (Fig. 1 B).

Decline in eGFR creat was significantly greater in subjects above the 300 mg/g threshold (p < 0.01), while the 30 mg/g threshold showed a trend toward larger decline (p = 0.054).

Interestingly, testosterone showed a trend to increase power in the beta band ( p = 0.054) and did in the gamma band ( p = 0.045).

Corneal hysteresis showed a trend toward larger values at 15 mmHg compared to 25 mmHg (0.283 ± 0.133 vs. 0.131 ± 0.041, p = 0.054) ( Figure 6B ).

No significant differences were noted in sex or ethnicity, although African-Americans showed a trend toward receiving vancomycin within guidelines (p = 0.054).